跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CYMBALTA 30 MG CAPSULAS DURAS GASTRORRESISTENTES - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
CYMBALTA 30 MG CAPSULAS DURAS GASTRORRESISTENTES
Approved
STANDARD
CYMBALTA 30 MG CAPSULAS DURAS GASTRORRESISTENTES
Eli Lilly Nederland B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 21, 2023
Approval ID
48466b91e8c33c14
Company
Eli Lilly Nederland B.V.
Type
Standard
Approval Details
Approval Id
48466b91e8c33c14
Drug Cima Aemps Name
CYMBALTA 30 MG CAPSULAS DURAS GASTRORRESISTENTES
Register Number
04296001IP2
Holder Company Name
Eli Lilly Nederland B.V.
Marketing Company Name
Melyfarma S.L.
Holder Company Detail Path
/organization/eli-lilly-nederland-bv
Authorization Date
2023-09-21
Dosage Form
CÁPSULA DURA GASTRORRESISTENTE
Dose
30 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Eli Lilly Nederland B.V.
Company Detail Path
/organization/eli-lilly-nederland-bv
Company Information
Pharmaceutical Company Name
Eli Lilly Nederland BV
Country Name
Netherlands
Website
http://www.lilly.com/nl
Active Ingredients
DULOXETINA HIDROCLORURO
30 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 21, 2023
Approval ID
48466b91e8c33c14
Type
Standard
Back to CIMA-AEMPS Approvals
